RAD51 foci in patients with ovarian cancer: association with treatment outcomes
Transcriptional landscape of 3D vs2D ovarian cancer models
Description of ovarian cancer patients with brain metastases
Differential regulation of genes by the glucogenic hormone asprosin in ovarian cancer
Preclinical studies on the effect of Rucaparib in ovarian cancer: impact of BRCA2 status
Identification of Potential Bisphenol A (BPA) Exposure Biomarkers in Ovarian Cancer
Identification of Cancer-Associated Circulating Cells in Anal Cancer Patients.
Perioperative detection of circulating tumour cells in patients with lung cancer
Role of RAD51AP1 in ovarian and lung cancer
Prognostic value of the DNA integrity index in patients with malignant tumours
Effects of rapalogues, resveratrol and dual kinase inhibitors on human ovarian carcinoma cells
Human C1Q induces apoptosis in an ovarian cancer cell line via Tumour Necrosis Factor pathway
Liquid biopsies in lung cancer: four emerging technologies and potential clinical applications
Surfactant Protein D as a Potential Biomarker and Therapeutic Target in Ovarian Cancer
Kinase Inhibitors and Ovarian Cancer
Involvement of the Endocrine-Disrupting Chemical Bisphenol A (BPA) in Human Placentation